{"id":"https://openalex.org/W2084447650","doi":null,"title":"Cardiovascular and gastrointestinal toxicity of selective cyclo-oxygenase-2 inhibitors in man.","display_name":"Cardiovascular and gastrointestinal toxicity of selective cyclo-oxygenase-2 inhibitors in man.","publication_year":2008,"publication_date":"2008-08-01","ids":{"openalex":"https://openalex.org/W2084447650","mag":"2084447650","pmid":"https://pubmed.ncbi.nlm.nih.gov/18812633"},"language":"en","primary_location":{"id":"pmid:18812633","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18812633","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of physiology and pharmacology : an official journal of the Polish Physiological Society","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028481030","display_name":"Esam Zapher Dajani","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E Z Dajani","raw_affiliation_strings":["International Drug Development Consultants Corporation, Long Grove, Illinois 60047-9532, USA. EsamD@aol.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"International Drug Development Consultants Corporation, Long Grove, Illinois 60047-9532, USA. EsamD@aol.com","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110654586","display_name":"K Islam","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K Islam","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":5.3588,"has_fulltext":false,"cited_by_count":101,"citation_normalized_percentile":{"value":0.9558871,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":100},"biblio":{"volume":"59 Suppl 2","issue":null,"first_page":"117","last_page":"33"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cox-2-inhibitors","display_name":"COX-2 inhibitors","score":0.9089999794960022},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.8600000143051147},{"id":"https://openalex.org/keywords/gastrointestinal-toxicity","display_name":"gastrointestinal toxicity","score":0.9950000047683716},{"id":"https://openalex.org/keywords/nonsteroidal-anti-inflammatory-drugs","display_name":"nonsteroidal anti-inflammatory drugs","score":0.8740000128746033},{"id":"https://openalex.org/keywords/rofecoxib","display_name":"rofecoxib","score":0.8730000257492065},{"id":"https://openalex.org/keywords/celecoxib","display_name":"celecoxib","score":0.9129999876022339},{"id":"https://openalex.org/keywords/valdecoxib","display_name":"valdecoxib","score":0.9639999866485596},{"id":"https://openalex.org/keywords/myocardial-infarction","display_name":"myocardial infarction","score":0.9369999766349792},{"id":"https://openalex.org/keywords/gastrointestinal-ulcers","display_name":"gastrointestinal ulceration","score":0.5249999761581421},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5770000219345093},{"id":"https://openalex.org/keywords/eicosanoids","display_name":"eicosanoids","score":0.5730000138282776},{"id":"https://openalex.org/keywords/cox-1-inhibition","display_name":"COX-1 inhibition","score":0.5580000281333923}],"concepts":[{"id":"https://openalex.org/C2778582115","wikidata":"https://www.wikidata.org/wiki/Q411412","display_name":"Rofecoxib","level":4,"score":0.8587750196456909},{"id":"https://openalex.org/C2776467144","wikidata":"https://www.wikidata.org/wiki/Q408801","display_name":"Celecoxib","level":2,"score":0.7845309972763062},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7650551795959473},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.6636022925376892},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6355167031288147},{"id":"https://openalex.org/C2779689624","wikidata":"https://www.wikidata.org/wiki/Q410251","display_name":"Cyclooxygenase","level":3,"score":0.6150925755500793},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5947183966636658},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.45038723945617676},{"id":"https://openalex.org/C2780886150","wikidata":"https://www.wikidata.org/wiki/Q152234","display_name":"Edema","level":2,"score":0.44621214270591736},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3245004117488861},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.1280466914176941},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.09628427028656006},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07870954275131226}],"mesh":[{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D005767","descriptor_name":"Gastrointestinal Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017723","descriptor_name":"Drug Utilization Review","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D052246","descriptor_name":"Cyclooxygenase 2 Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:18812633","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18812633","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of physiology and pharmacology : an official journal of the Polish Physiological Society","raw_type":"Journal Article"},{"id":"mag:2084447650","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18812633","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":44,"referenced_works":["https://openalex.org/W174601305","https://openalex.org/W1576358752","https://openalex.org/W1965992514","https://openalex.org/W1972283919","https://openalex.org/W1976110335","https://openalex.org/W1976365391","https://openalex.org/W1985210212","https://openalex.org/W1989081972","https://openalex.org/W1995355693","https://openalex.org/W1995528018","https://openalex.org/W2001162433","https://openalex.org/W2001676690","https://openalex.org/W2003614670","https://openalex.org/W2010390914","https://openalex.org/W2012920835","https://openalex.org/W2018035901","https://openalex.org/W2021041600","https://openalex.org/W2027645788","https://openalex.org/W2032997277","https://openalex.org/W2037619899","https://openalex.org/W2038410983","https://openalex.org/W2038932922","https://openalex.org/W2062335942","https://openalex.org/W2063252400","https://openalex.org/W2065689558","https://openalex.org/W2067621583","https://openalex.org/W2076700081","https://openalex.org/W2080674779","https://openalex.org/W2092193486","https://openalex.org/W2097780727","https://openalex.org/W2100631748","https://openalex.org/W2110809844","https://openalex.org/W2117935315","https://openalex.org/W2132450168","https://openalex.org/W2132552005","https://openalex.org/W2134270369","https://openalex.org/W2141792971","https://openalex.org/W2145707658","https://openalex.org/W2145816148","https://openalex.org/W2148359829","https://openalex.org/W2155820793","https://openalex.org/W2163756514","https://openalex.org/W2330496155","https://openalex.org/W2467116370"],"related_works":["https://openalex.org/W184022295","https://openalex.org/W7095168900","https://openalex.org/W2009486610","https://openalex.org/W2123175521","https://openalex.org/W2170109137","https://openalex.org/W2160378840","https://openalex.org/W2277790565","https://openalex.org/W2037967805","https://openalex.org/W2037678543","https://openalex.org/W2083462425"],"abstract_inverted_index":{"It":[0],"is":[1,56,301],"well":[2],"established":[3],"that":[4],"the":[5,14,17,22,62,75,94,107,114,120,124,129,163,177,226,253,271,290,323,343],"use":[6,198],"of":[7,16,24,44,53,61,116,228,242,249,257,274,329,345],"traditional":[8,35,296],"nonsteroidal":[9],"anti-inflammatory":[10],"drugs":[11],"(NSAIDs)":[12],"increase":[13],"vulnerability":[15],"gastrointestinal":[18],"(GI)":[19],"mucosa":[20],"for":[21,69,81,293],"development":[23],"peptic":[25],"lesions":[26],"and":[27,34,65,144,183,211,237,276,295,303,307,325,335],"serious":[28],"ulcer":[29],"complications.":[30],"In":[31,193],"addition,":[32],"selective":[33,213,337],"NSAIDs":[36,73,100,331],"have":[37,135],"also":[38,92,279],"been":[39,136],"associated":[40,180,200,218],"with":[41,152,181,201,209,246],"increased":[42],"frequency":[43],"cardiovascular":[45,66],"toxicity,":[46],"especially":[47],"in":[48,86,93,119,128,281,289],"susceptible":[49],"patients.":[50],"The":[51,215],"objective":[52],"this":[54,190],"communication":[55],"to":[57,104,138,175,270,309,341],"provide":[58],"an":[59,110],"overview":[60],"salient":[63],"GI":[64,142,146,326],"(CV)":[67],"toxicity":[68,159,220,266,300],"these":[70],"drugs.":[71],"Traditional":[72],"inhibit":[74,106],"constitutional":[76],"cyclooxygenase-1":[77],"(COX-1)":[78],"enzyme":[79,112],"responsible":[80],"eicosanoids":[82,118,127],"biosynthesis":[83],"not":[84,267],"only":[85,268],"joints,":[87],"a":[88,96,247],"beneficial":[89],"effect,":[90],"but":[91,122,278,284],"stomach,":[95],"detrimental":[97],"effect.":[98],"Selective":[99,131],"were":[101,172,252],"specifically":[102],"designed":[103],"preferentially":[105],"cyclooxygenase-2":[108],"(COX-2),":[109],"inducible":[111],"mediating":[113],"production":[115],"inflammatory":[117],"joints":[121],"sparing":[123],"endogenous":[125],"protective":[126],"stomach.":[130],"COX-2":[132],"inhibitors":[133,187,217,338],"(COXIBs)":[134],"shown":[137,189],"possess":[139],"much":[140],"improved":[141],"tolerability":[143],"reduced":[145],"related":[147],"adverse":[148],"events":[149,259],"when":[150,207],"compared":[151,208],"nonselective":[153],"COX-1":[154],"inhibitors.":[155,263,347],"An":[156],"unexpected":[157],"CV":[158,178,191,205,219,243,250,258,265,299,324],"had":[160,188],"emerged":[161],"during":[162],"COXIBs":[164,182],"post":[165],"marketing":[166,272],"outcome":[167],"studies.":[168],"Many":[169],"subsequent":[170],"studies":[171],"carried":[173],"out":[174],"define":[176],"risks":[179],"NSAIDs.":[184,214],"All":[185],"COX":[186,216,262,315,346],"toxicity.":[192],"many":[194],"clinical":[195],"studies,":[196],"rofecoxib":[197,275],"was":[199],"significantly":[202],"more":[203,282],"elevated":[204],"risk":[206,241],"celecoxib":[210,294],"non":[212],"has":[221],"multiple":[222],"manifestations,":[223],"which":[224],"include":[225],"induction":[227],"myocardial":[229],"infarction":[230],"(MI),":[231],"edema,":[232],"thrombosis,":[233],"blood":[234],"pressure":[235],"destabilization":[236],"death.":[238],"Patients":[239],"at":[240],"disease":[244,251],"or":[245],"history":[248],"most":[254],"significant":[255],"determinants":[256],"after":[260],"receiving":[261],"This":[264,298],"led":[269],"withdrawal":[273],"valdecoxib":[277],"resulted":[280],"restricted,":[283],"essentially":[285],"identical,":[286],"product":[287],"labels":[288],"United":[291],"States":[292],"NSAIDS.":[297],"dose":[302],"treatment":[304],"duration":[305],"dependent":[306],"appears":[308],"be":[310],"compound":[311],"specific":[312],"rather":[313],"than":[314],"specific.":[316],"Additional":[317],"comprehensive,":[318],"long-term,":[319],"prospective":[320],"investigations":[321],"comparing":[322],"safety":[327],"profile":[328],"marketed":[330],"against":[332,336],"each":[333],"other":[334],"are":[339],"needed":[340],"address":[342],"controversy":[344]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":11},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":16},{"year":2012,"cited_by_count":9}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}